
Mayadevi Polycot Limited Discloses Acquisition of IOL Chemicals & Pharmaceuticals Shares
Mayadevi Polycot Limited has acquired 54,197 equity shares of IOL Chemicals and Pharmaceuticals Limited through open market transactions on March 19, 2026. The disclosure was made under Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.According to the filing, Varinder Gupta, Varinder Gupta (HUF), NCVI Enterprises Limited, and Mayadevi Polycot Limited collectively held 16,75,58,303 shares, representing 57.08% of the total share/voting capital and 57.08% of the total diluted share/voting capital of IOL Chemicals and Pharmaceuticals Limited prior to the acquisition.
The acquisition of the 54,197 shares increased the collective holding to 16,76,12,500 shares, representing 57.10% of the total share/voting capital and 57.10% of the total diluted share/voting capital of IOL Chemicals and Pharmaceuticals Limited. The total equity share capital of IOL Chemicals and Pharmaceuticals Limited is Rs. 58,70,55,020, equivalent to 29,35,27,510 equity shares of Rs. 2 each.
Shareholding Details
The following table summarizes the shareholding details:
| Detail | Varinder Gupta | Varinder Gupta (HUF) | Mayadevi Polycot Limited | NM Merchantiles Limited | NCVI Enterprises Limited |
|---|---|---|---|---|---|
| Shares carrying voting rights before acquisition | 59,79,325 | 5,500 | 6,38,91,133 | 5,01,31,650 | 4,75,50,695 |
| Total Shares carrying voting rights before acquisition | 16,75,58,303 | ||||
| Shares acquired | 54,197 | ||||
| Total Shares carrying voting rights after acquisition | |||||
| % w.r.t. total share/voting capital | |||||
| % w.r.t. total diluted share/voting capital |
Varinder Gupta serves as Director of Mayadevi Polycot Limited (DIN: 00044068).
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Last edited by a moderator: